Asset vs asset
Hedera is a HBAR market beta asset with $4.05B in market cap, while Injective is a INJ market beta asset with $303.19M. The useful comparison is market role, liquidity, seven-day direction, and which follow-up page gives the cleaner next decision.
Comparison Table
| Question | Hedera | Injective |
|---|---|---|
| Market role | HBAR market beta asset | INJ market beta asset |
| Price | $0.09346 | $3.03 |
| Market cap | $4.05B | $303.19M |
| 24h volume | $89.13M | $38.31M |
| 7d change | -2.73% | -1.11% |
| Relative size | Hedera is 13.35x Injective's market cap | Injective is 0.07x Hedera's market cap |
| Volume comparison | Hedera trades at 2.33x Injective's 24h volume | Injective trades at 0.43x Hedera's 24h volume |
Use the market-cap calculator when the real question is what one asset would imply at another size.
Open calculatorA cleaner comparison still needs a practical plan for exchanges, withdrawals, and wallets.
Open checklistPut both names back into the wider market context before treating the comparison as a final answer.
Open markets